Sampling Procedures in Estrogen Receptor Determinations by NEWSOME, JAMES et al.
Sampling Procedures in Estrogen Receptor Determinations
JAMES F. NEWSOME, M.D.,* FREDERICK P. AVIS, M.D.,* JOHN E. HAMMOND, PH.D.,t SUSAN SHERWOOD, B.S.t
To determine the significance of proteolysis and delayed freez-
ing of ttmor samples on estrogen receptor levels, values from
19 of 31 biopsy specimens were compared with that in remain-
ing tumor at the completion of mastectomy. There was a
15-100% decrease in receptor content. Time-decay studies on
selected postmastectomy samples showed a further decrease in
estrogen receptor content inversely proportional to the time it
was exposed to room temperature. Factors that govern the valid
measurement of receptor levels include tumor cell concentra-
tion, tumor necrosis, and time between devascularization of the
specimen to freezing. A carefully procured histologically con-
firmed sample offresh tumor is necessary for reliable estrogen
receptor values.
T HE ROLE OF STEROID hormone receptors in the
management of hormone-dependent tumors is
well-established. Among the various parameters that
may influence the measurement of receptors in tumor
tissue are the thermal lability and the proteolytic sus-
ceptibility of the receptor hormone complex.4 To
evaluate the influence of the time of sample procure-
ment and the significance of time lapsed between de-
vascularization of the tumor to specimen freezing, the
following study was undertaken. Estrogen receptor
levels were determined from histologically confirmed
adenocarcinoma of the breast frozen immediately after
biopsy and compared with levels taken from the same
cancer at the completion of the mastectomy.
Procedure and Methods
An appropriate sample of breast tumor was procured
at open biopsy under 1% lidocaine anesthesia, adminis-
tered locally, in the Outpatient Department. The
presence of cancer was confirmed by immediate frozen
section. Following the removal of fat, grossly necrotic
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and hemorrhagic tissue, the remaining sample was
rapidly frozen in liquid nitrogen and submitted for de-
termination of estrogen receptor concentration. These
results were compared with those determined from
samples of the same tumor taken at the time of comple-
tion of the mastectomy. After the determination of a
significant decrease in receptor levels in four of five
mastectomy specimens when compared with biopsy
specimens (Table 1), time-decay studies of the mastec-
tomy specimens were undertaken. The initial study
yielded inconsistent valups, presumably the result of
varying tumor density' within the specimen studied
(Table 2). Subsequently, the remaining tumors in the
mastectomy specimens were minced into 1-2 mm por-
tions, thoroughly mixed, and random samples frozen
at 15 minute intervals for subsequent measurement of
receptor levels (Fig. 1).
Tissue specimens were stored at -70 C until the time
of analysis. On the day of analysis the specimens were
thawed, freeze fractured and hqmogenized. Cellular
debris were removed by ultracentrifugation and the re-
sulting cytosol was diluted to a final protein concentra-
tion of approximately 2.0 mg/ml. A five-point dextran-
coated charcoal saturation analysis was performed.
Scatchard data analysis was done and the best line was
obtained by least squares regression analysis. All speci-
mens showed dissQciation c'onstants (Kd) of less than
10-10 moles/L and binding capacity was expre4sed as
femtomoles (10-15 moles) of 3H estradiol per milligram
of cytosol protein. The data presented in this paper
show changes in estrogen receptor content between
multiple specimens analyzed in the same assay. We find
that the intra-assay and interassay coefficients of varia-
tion are approximately + 10 and ± 15%, respectively.
In our laboratory, levels above 10 femtomoles per
milligram of cytoplasmic protein are considered posi-
tive, 3-10 femtomoles, borderline, and below 3 femto-
moles, negative. Those tumors found at initial biopsy
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to be receptor-negative were not further studied. Both
biopsy and mastectomy specimens were frozen within
15 minutes of the time of removal. Care was taken not
to expose the tumor to electrocoagulation.3 Most pa-
tients underwent a modified radical mastectomy from
one to seven days following biopsy, with two excep-
tions, who, because of medical and personal reasons,
underwent mastectomy 21 and 26 days, respectively,
following biopsy. The mean time from the beginning of
mastectomy to harvesting the specimen for receptor de-
termination was approximately two and one-half hours.
Results
During the period of this study, 59 patients were
proved at open biopsy to have previously untreated
breast cancer. Thirty-one patients had adequate
amounts of cancer remaining in the mastectomy speci-
TABLE 2. Time-Decay Study of Estrogen Receptor
Concentration in Breast Cancer




Patients mens 15 30 60 90 120
6* 123 x 184 316 244 240
7 43 15 17 8 5 3
8 5 3 7 3 4 3
9 9 <3 <3 <3 <3 <3
10 171 11 (Inadequate Tissue)
11 89 17 7 7 9 11
12 218 305 267 268 182 112
13 56 <3 (Tissue Necrotic)
14 37 <3 <3 9 3 16
15 5 3 4 3 <3 <3
16 21 <3 <3 <3 <3 4
17 4 3 <3 <3 <3 <3
18 5 5 x <3 <3 x
19 5 39 (Inadequate Tissue)
* Time studies without mincing technique.
x: Not done.
men to be included in this study. Nineteen patients
(61%) had receptor levels of 3 femtomoles or greater,
seven (35%) of which were in the borderline range
(3-10 femtomoles). Though the receptor concentration













FIG. 1. Technique for
a/ preparation of postmastec-
tomy tumor samples for
time-decay studies.
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they were, nevertheless, studied. The sample from one
such patient (#19) was shown to have significant re-
ceptor concentration in the mastectomy specimen,
though the biopsy specimen was low borderline. The
results of the 19 studies are depicted in Tables 1 and 2.
Of the paired specimens which contained a bio-
logically significant amount of estrogen receptors
(greater than 10 femtomoles per milligram), ten (83%)
showed a decrease and two (16.6%) increased in recep-
tor content (Fig. 2). Because of technical reasons, the
15 minute postmastectomy receptor level in one (Num-
ber 6) was not determined and is thus not included. It
was the variability of results in this time-decay study





















FIG. 2. Changes in estrogen receptor concentration, biopsy vs.
mastectomy specimen in the 18 studied patients. (Patient number
6 not included; two samples had identical values.) Note the difference

















FIG. 3. Estrogen receptor concentration, biopsy vs. mastectomy
specimen in selected patients. Five patients would have been judged
borderline or negative had the postmastectomy values been relied
upon.
Changes in estrogen receptor levels in tumor samples
from 11 patients demonstrated a reduction from the
biopsy to postmastectomy that ranged from 15 to 100%,
with a mean of 70%. In one patient (Number 12) there
was a significantly higher value for the mastectomy spec-
imen. Five of the 11 samples (45%) would have been
judged borderline or negative had the results of the
postmastectomy specimen been relied upon (Fig. 3).
Of the 13 postmastectomy specimens submitted for
time-decay studies, five had adequate receptor levels
in the initial 15 minute sample to permit evaluation
(Fig. 4). All time specimens were analyzed in one
batch. Each of these specimens showed the expected
decrease in receptor levels with time though there was
some variability. This change may be due to analytic
variation or to sampling error despite attempts to con-
trol for this.
Discussion
Analysis of the data shows a significant drop in tumor
receptor content occurring in the interval between open
biopsy and completion of mastectomy. While the
time-decay studies suggest that proteolysis and/or
thermal decay may result from separation of the tumor
from its blood supply, other factors are, doubtless, im-
portant. Though the electrocautery was not employed
at either the biopsy or mastectomy, it seems reasonable
to attribute some of the difference in receptor levels to
tissue necrosis resulting from ligatures, tumor manipu-
lation, and from hematoma generated at the time of
biopsy. Further work is necessary to document the sta-
bility of receptors under various conditions. In this re-
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FIG. 4. Time-decay estrogen receptor studies, mastectomy speci-
mens. Changes in estrogen receptor levels in postmastectomy
tumor samples with increasing time at room temperature. Only
those showing change are included. Note scale difference.
gard it would have been informative had time-decay
studies been carried out on the biopsy sample.
It is tempting to speculate that the variously reported
objective responses to endocrine therapy of estrogen
receptor negative tumors of 1-14% may reflect inade-
quate attention to sample procurement.2
In many centers, the traditional open biopsy-frozen
section-mastectomy sequence has been replaced with
schemes that result in hospital admission only after
histologic confirmation of the presence of cancer, and
the complete assessment of the extent of disease; pro-
cedures that in most instances have a sound medical,
economic, and humane logic. Whatever the sequence
employed, it is apparent that high priority should be
given to the procurement of a fresh sample with the
presence of adequate tumor histologically confirmed,
and that any technique resulting in tumor necrosis must
be assiduously avoided if the steroid hormone receptor
levels are to be reliable.
We conclude that estrogen receptors are greatly al-
tered by proteolysis and/or thermal decay and to a cer-
tain extent are inversely proportional to the time from
separation of blood supply to freezing of the tumor
specimen. To insure valid determinations of estrogen
receptor levels in tumor tissue, we recommend that any
sequence for the diagnosis and treatment of breast
cancer include the rapid freezing of a carefully pro-
cured, histologically confirmed sample offresh tumor.
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DISCUSSION
DR. RALPH B. VANCE (Jackson, Mississippi): About 65% of the
human breast tumor tissue contains measurable amounts of estro-
gen receptor protein, and about 60%o of those tumors which are es-
trogen receptor positive will show tumor regression when treated
with hormones alone. This means that about 39o of the patients with
breast carcinoma can expect to respond to hormone treatment alone,and therefore we consider the importance ofobtaining accurate meas-
urements of the receptor from the assay without false negativeresults.
Probably the most important point in this well-done paper is the
recognition of borderline positive samples which would otherwise
have been missed. Specifically, Dr. Newsome's slide Samples 1 and3 would yield false negative results if the mastectomy specimensalone were the only data base. At our institution, we have requestedthat the temperature of the specimen container be cooled to -20°in order to facilitate freezing as much as possible, and thereby toavoid decay. I think the point is well taken in this paper.
DR. J. SHELTON HORSLEY, III (Richmond, Virginia): I believe es-
trogen receptors are a very important piece of information. Certainly,
today it is a vital determination in planning the treatment of a woman
who has metastatic breast cancer. I think, in the very near future, it
will play a major role in selecting the proper type of adjuvant therapy
for women with primary breast cancer who have metastases in their
axillary nodes.
There have been some disturbing findings with regard to the analy-
ses for estrogen receptors. When the results of various laboratories
performing these tests have been compared with standardized
powders, an error in approximately 33% has been found. It is well
known that there are different values found within the same speci-
men, as Dr. Newsome has pointed out; and now he has called our
attention to the fact that there is a difference with regard to time
delay.
We have done several of these studies and our variability is so
great that we don't know exactly what to make of it. However,
we should all be attentive to the point that as soon as possible upon
completion of the mastectomy, the specimen should be carefully pre-
